Indiana Life Sciences Capital: A summary of 2022 investments
Indiana’s life sciences sector contributed $77 billion to the state’s economy last year. Total market cap value grew by 20 percent over 2021, from $455.7 billion to $548.7 billion, driven largely by Eli Lilly and Company. Elevance Health, Corteva Agriscience, POINT Biopharma Global Inc., and Zimmer Biomet Holdings, Inc. also posted market cap gains.
BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups; building new enterprises; and educating through conferences, reports and market development knowledge.
NEWSLETTER SIGN UP
1210 Waterway Boulevard,
Indianapolis, IN 46202